Pulmonary Fibrosis Foundation Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2009
NCT00981747
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Pulmonary Fibrosis Foundation

Active Ingredients

Drugs in Phase 3 Trials (3)

acetylcysteine (mucomyst) (1 trial)

losartan (cozaar) (1 trial)

sildenafil (viagra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 3)

Idiopathic Pulmonary Fibrosis (Phase 3)

Pulmonary Fibrosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3